Taiwo Olabisi: Exploring the Promise of Factor XIa Inhibitors in Stroke Prevention
Taiwo Olabisi, Registered Nurse at Lasuth, shared a post on LinkedIn:
“Closed my laptop today feeling incredibly fulfilled. I just completed an advanced pharmacotherapy certification: ‘Less Bleeding, More Prevention: A Nurse-Focused Review of the Paradigm-Shifting Promise of Factor XIa Inhibitors in Secondary Stroke Prevention.’
While working in a busy surgical department, you quickly realize that patient care doesn’t stop when the surgery ends.
Post-op recovery is a critical window, and thromboembolic events (like strokes or deep vein clots) are risks we have to watch like a hawk every single shift.
Taking this course gave me a much deeper look into the latest low-bleed anticoagulation protocols, which means I can bring sharper eyes and better clinical judgment straight to the ward floor tomorrow.
Investing in my education is non-negotiable for me, especially as I keep looking toward global standards and expanding my horizons in healthcare.
One milestone at a time!”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering